Jeffrey V. Lazarus
@JVLazarus
Followers
9K
Following
24K
Media
3K
Statuses
22K
Committed to people-centred health systems. Director #SLDthinktank. Professor @CUNYSPH @ISGLOBALorg @JVLazarus.bsky.social Loraxian #LiverTwitter
CPH • BCN • NYC • En el Camino
Joined November 2012
Today is the day! The @Nature #COVIDconsensus paper is now live at All of our recommendations are 100% within human control and we need your help to spread the message to end #COVID19 as a #publichealth threat! #CovidTwitter
100
1K
3K
RT @PojsakornDan: Our commentary is now available on @LancetRH_WPac Multisystem burden in cirrhosis: lessons from a marginalised populatio….
0
3
0
RT @LancetRH_Europe: 🚨 New podcast! Join liver experts Prof @JVLazarus & Prof John Dillon as they unpack chronic liver disease, #MASLD & #M….
0
1
0
Bumping this up after discussions today with @brennap9 on how we automatise liver disease testing. We need to move from HCV reflext testing to automated reflext testing for all liver diseases. And there is a cost-effective solution to do this.
@DrJavierCrespo @fegarciagarcia @sepdigestiva @AEEHLiver @GEHEP_ Yup, reflex testing for hepatitis C is not only cost-effective but just makes good sense, for the #healthsystem and the patient. Great study. We push for simplification here: @ProfJohnDillon @Mariabutif @JurgenRockstroh @capicchio #NoHep.
1
0
5
I left Mexico yesterday with good news through the grapevine and landed in Copenhagen to the FDA announcement that semaglutide injection to treat metabolic-associated steatohepatitis (MASH) was approved:. #LiverTwitter #SLDthinktank
0
2
10
RT @EASLnews: EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in he….
0
37
0
Hepatitis B vaccination is liver cancer prevention, and so is treating MASLD and reversing fibrosis. Both need to be mentioned by name in the Political declaration of the UN General Assembly High-level Meeting on NCDs in Sept. The GMHR will make it happen:
isglobal.org
🎥🎥 🟩 Marko Korenjak 🇸🇮 , President of ELPA and dedicated advocate for millions of liver patients across Europe, delivers a powerful message as part of the ELPA Working Group for Hepatitis B & D. 🛡 Prevention is Possible.💉 Vaccination Saves Lives.📚 Education Empowers
1
9
18
RT @ISGLOBALorg: This year’s #WorldHepatitisDay theme, “Let’s break it down,” is more than just a slogan. It’s a call to action to:.🔹 Break….
0
3
0
RT @LiverAim: 🚨 Don't miss the third webinar of the #LIVERAIM series!. 📹 #livertwitter #SLDthinktank.@IHIEurope @….
0
6
0
Recent expert commentary and the flagship event of the Global Think-Tank signal a long-overdue policy reckoning for chronic liver disease.#LiverTwitter #SLDthinktank @AASLDtweets @IntDiabetesFed @EASLEUAffairs @ncdalliance @WorldObesity @FattyLiverA
1
8
23
RT @IntDiabetesFed: #IDF75- 65 days until our 75th anniversary! We continue our countdown to 23 September by looking back at some key momen….
0
5
0
Well, I guess @nickcave won't be repeating that exhibition. Was lucky to see it with my daughter at the Royal Library in Copenhagen. amazing donation of 2,000 books:.
0
0
2
RT @NoureddinMD: A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis.@JVLazarus @TheLancet….
pubmed.ncbi.nlm.nih.gov
Metabolic dysfunction-associated steatohepatitis (MASH) is an increasingly important contributor to morbidity and mortality. Little emphasis has been placed on its timely diagnosis and interventions...
0
7
0
RT @rabataller: Two key points that we need to remember about the new SLD (Steatotic Liver Disease) nomenclature:. 1️⃣ SLD ≠ MASLD — it als….
0
24
0
RT @SFesPamplona: 🔻🎉 ¡Ya han comenzado los #Sanfermines2025! #sanferminespamplona.¡Viva San Fermín! Gora San Fermín! ¡¡Felices fiestas!! ht….
0
28
0
RT @scottisaacsmd: Excellent editorial in the @NEJM about the need to redefine clinical endpoints in MASH cirrhosis trials. With up to 25%….
0
28
0
JUST OUT: "The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)".In 2021, MASLD had a prevalence of 1.27 billion people while T2DM had a prevalence of 0.51 billion people worldwide. #LiverTwitter @PojsakornDan.
onlinelibrary.wiley.com
Background Metabolic diseases are a public health threat to diverse populations worldwide. This study aims to update the epidemiological trends of metabolic diseases across regions and sociodemogra...
0
16
46
The Global Metabolic Health Roundtable series recently held 3 regional meetings to unite leaders in Asia, Latin America and the MENA regions in supporting the call to include chronic liver disease in the UNGA HLM Declaration, aligned w the #SLDthinktank.
sldthinktank.com
Briefing note Chronic Liver Disease, MASLD/MASH, and the Global NCD Agenda The UN General Assembly High-Level Meeting (HLM) on the Prevention and Control of Noncommunicable Diseases (NCDs), in...
0
1
4
From steatotic liver disease to #Catanconnect today with 40 countries playing. We crushed it including longest road in Denmark and the intermission prize. So fun to disconnect and take over the island 😂
0
0
5
An important correspondence and here is our response We need to continue to grow the MASLD community of practice. #LiverTwitter.
nature.com
Nature Reviews Gastroenterology & Hepatology - Reply to ‘Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field’
New online! Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field
1
1
12
RT @NatRevGastroHep: New online! Reply to ‘Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field’ h….
nature.com
Nature Reviews Gastroenterology & Hepatology - Reply to ‘Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field’
0
6
0